339 related articles for article (PubMed ID: 16101181)
1. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
[TBL] [Abstract][Full Text] [Related]
2. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
3. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
Stohl W; Elliott JE; Lynch DH; Kiener PA
J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
[TBL] [Abstract][Full Text] [Related]
4. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
[TBL] [Abstract][Full Text] [Related]
5. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
Noble A; Pestano GA; Cantor H
J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
7. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
Stohl W; Lynch DH; Starling GC; Kiener PA
J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
[TBL] [Abstract][Full Text] [Related]
8. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a novel superantigen fusion protein: bFGF/SEB.
Wang L; Zhang H; Zhang S; Yu M; Yang X
Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106
[TBL] [Abstract][Full Text] [Related]
11. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
Hsu LJ; Jan MS; Lin YS
Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
[TBL] [Abstract][Full Text] [Related]
12. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2.
McKay DM; Singh PK
J Immunol; 1997 Sep; 159(5):2382-90. PubMed ID: 9278329
[TBL] [Abstract][Full Text] [Related]
13. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.
Sänger C; Busche A; Bentien G; Spallek R; Jonas F; Böhle A; Singh M; Brandau S
BMC Cancer; 2004 Nov; 4():86. PubMed ID: 15566565
[TBL] [Abstract][Full Text] [Related]
14. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha.
Shinbori T; Walczak H; Krammer PH
Eur J Immunol; 2004 Jun; 34(6):1762-70. PubMed ID: 15162447
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
16. Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris.
Yamamoto T; Katayama I; Nishioka K
Eur J Dermatol; 1998; 8(5):325-9. PubMed ID: 9683864
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
Perabo FG; Kamp S; Schmidt D; Lindner H; Steiner G; Mattes RH; Wirger A; Pegelow K; Albers P; Kohn EC; von Ruecker A; Mueller SC
Br J Cancer; 2001 May; 84(10):1330-8. PubMed ID: 11355943
[TBL] [Abstract][Full Text] [Related]
18. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
D'Orazio JA; Burke GW; Stein-Streilein J
J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
[TBL] [Abstract][Full Text] [Related]
20. Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4.
Lu J; Philpott DJ; Saunders PR; Perdue MH; Yang PC; McKay DM
J Pharmacol Exp Ther; 1998 Oct; 287(1):128-36. PubMed ID: 9765331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
